Sonablate

Sonablate Corp. is a global leader in the field of artificial intelligence-based ultrasound therapy. Since inventing the world's first ultrasound cancer treatment device, Sonablate HIFU has achieved a technological leap in performing non-invasive tumor surgeries independently, without relying on other imaging equipment, after decades of continuous innovation, refinement, and the accumulation of worldwide clinical application data. "AI-driven automated treatment, real-time intraoperative imaging tracking, precise and non-invasive treatment, gland-preserving focal therapy" have become the hallmark technologies of Sonablate Corp.'s products, standing at the forefront of global medical theory innovation and clinical practice.